Elym Discovery is developing computational frameworks to automate predictive bioactivity modelling and taxonomic characterisation for the global oral and dental healthcare therapeutics sector. Our secure, computer-implemented data pipelines are designed to process text-based genomic marker data, with the aim of accelerating formulation timelines and reducing reliance on traditional wet-lab screening.
Two Phases
Intended to help smaller brands prioritise promising natural-product candidates computationally before committing to costly CRO validation.